HEALTHWGN9 CHICAGO
Medicare launches pilot program expanding access to GLP-1 drugs
Medicare has announced a pilot program to expand access to GLP-1 drugs. The program will run from July 1, 2026, to December 31, 2027.
Mentioned
Related Signal
Adjacent reporting
- Medicare launches pilot program expanding access to GLP-1 drugs
- Lilly’s GLP-1 medications will soon be covered by CVS, potentially opening access for millions of Americans
- Exclusive: Race begins to trial Ebola drugs amid current outbreak
- Denmark to Study Whether Wegovy Can Get More People Working
- Collector launches Yogandhra 2026 program
- Trump announces TrumpRx expansion, adding 160 more drugs